G0542S130

Newgenivf Group Limited

Could not find a ticker for this position, may be a filing error

A special purpose acquisition company—a "blank check" shell that raises money in an initial public offering, then hunts for a private company to merge with and take public. Founded in 2022 and incorporated in the British Virgin Islands, it set its sights on fast-growing technology, media, and telecom firms in the US and Asia, and in 2024 it merged with NewGenIvf, a fertility services provider. The name is a wink at the whole idea: "A SPAC I" spells out a pun on "spacy" and marks it as the first in a series of sponsor vehicles.

Warrant to purchase Class A ordinary shares

No Schedule 13D or 13G filings recorded.